Posts by Jason D. Roh, MD
-
Study Shows ActRII Signaling Contributes to Heart Failure and Aging
Researchers at Massachusetts General Hospital show that increased activin type II pathway receptor signaling contributes to heart failure and aging, and the findings may lead to new therapeutic targets in heart disease.
Biography
Dr. Jason Roh received his MD and MHS from Yale University School of Medicine. He completed his residency in internal medicine at Brigham and Women’s Hospital, followed by a fellowship in cardiovascular medicine at Beth Israel Deaconess Medical Center.
Dr. Roh’s clinical interests focus on cardiovascular care in the elderly, and he runs an inter-disciplinary geriatric-cardiology clinic in collaboration with the MGH SeniorHealth practice. His translational research explores the intersection between aging and cardiovascular disease, combining proteomics discovery-based investigations in humans with mechanistic work in animal models of cardiac aging and heart failure.
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.